Delivery Order SPE2DB20D9331-SPE2DB21FL1X3
Award Date
9/21/21
Potential Completion Date
9/22/21
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a firm fixed-price delivery order ceiling value of $4,541.76 and covers the supply of Telmisartan 20 mg tablets to fulfill the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite-delivery contract (IDC) with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,135.44 firm fixed-price delivery order is for the supply of Telmisartan 20 mg tablets and does not have a set-aside designation. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,671.69 firm fixed-price delivery order is for the provision of Telmisartan 40 mg tablets to support the recurring pharmaceutical supply needs of U.S. military healthcare facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,828 contract was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 indefinite delivery contract that enables DLA to place orders for a wide range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $3,848.60 issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract provides for the delivery of 4,565,252,933 tablets of the generic drug Tamsulosin Hydrochloride 0.4 mg to the DLA by July 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,906.39 contract is for the delivery of Micardis HCT 40-12.5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $10,634.97 contract is for the delivery of Micardis HCT 80-25 mg tablet units to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 through...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,425.24 firm fixed-price delivery order is for the supply of Micardis HCT 80-12.5 mg tablets, with a completion date of June 3, 2022. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB medical supply program. The contract has a ceiling value of $64,038.84 and a performance period through November 16, 2020. DMS Pharmaceutical Group provides a wide range of pharmaceuticals, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, under the SPE2DB program. The $2,460.12 contract is for the delivery of Micardis HCT 40-12.5 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...